These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19699069)

  • 1. Metabolic syndrome and cardiovascular risk prediction in peripheral arterial disease.
    Brevetti G; Laurenzano E; Giugliano G; Lanero S; Brevetti L; Luciano R; Chiariello M
    Nutr Metab Cardiovasc Dis; 2010 Nov; 20(9):676-82. PubMed ID: 19699069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication.
    Golledge J; Leicht A; Crowther RG; Clancy P; Spinks WL; Quigley F
    J Vasc Surg; 2007 Jan; 45(1):40-6. PubMed ID: 17123770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metabolic syndrome in patients with intermittent claudication and its correlation with the segment of arterial obstruction.
    Zerati AE; Wolosker N; Ayzin Rosoky RM; Fernandes Saes G; Ragazzo L; Puech-Leão P
    Angiology; 2010 Nov; 61(8):784-8. PubMed ID: 20395234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of the different components of the metabolic syndrome on cardiovascular risk].
    Donfrancesco C; Palmieri L; Giampaoli S; Vanuzzo D; Pilotto L; Panico S; Ferrario MM; Cesana G; Mattiello A; Chiodini P;
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):37S-42S. PubMed ID: 20879477
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between peripheral arterial disease and metabolic syndrome.
    Maksimovic M; Vlajinac H; Radak D; Marinkovic J; Jorga J
    Angiology; 2009; 60(5):546-53. PubMed ID: 19147526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of international guidelines on the management of cardiovascular risk factors in diabetic patients with peripheral arterial disease.
    Margeta C; Giurgea A; Hammer A; Schlager O; Zehetmayer S; Koppensteiner R; Willfort-Ehringer A
    Int Angiol; 2009 Jun; 28(3):175-80. PubMed ID: 19506537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic impact of general and abdominal obesity in peripheral arterial disease.
    Giugliano G; Brevetti G; Laurenzano E; Brevetti L; Luciano R; Chiariello M
    Int J Obes (Lond); 2010 Feb; 34(2):280-6. PubMed ID: 19935748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome.
    Morillas P; Quiles J; Cordero A; Guindo J; Soria F; Mazón P; Gonzalez-Juanatey JR; Bertomeu V;
    Am J Cardiol; 2009 Dec; 104(11):1494-8. PubMed ID: 19932781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in childhood obesity.
    Serap S; Mevlüt B; Inanç C; Ender S
    Indian Pediatr; 2007 Sep; 44(9):657-62. PubMed ID: 17921554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study.
    Assmann G; Schulte H; Seedorf U
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S11-6. PubMed ID: 18469834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals.
    He Y; Jiang B; Wang J; Feng K; Chang Q; Zhu S; Fan L; Li X; Hu FB
    Diabetes Care; 2007 Aug; 30(8):2128-34. PubMed ID: 17468350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using waist circumference to screen for metabolic syndrome in an inpatient population.
    Patel PV; Gilski D; Morrison J
    Crit Pathw Cardiol; 2010 Sep; 9(3):152-5. PubMed ID: 20802269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes.
    Ingelsson E; Sullivan LM; Murabito JM; Fox CS; Benjamin EJ; Polak JF; Meigs JB; Keyes MJ; O'Donnell CJ; Wang TJ; D'Agostino RB; Wolf PA; Vasan RS
    Diabetes; 2007 Jun; 56(6):1718-26. PubMed ID: 17369522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
    Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A
    Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
    Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
    Eur J Clin Invest; 2009 Jun; 39(6):437-44. PubMed ID: 19397692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.